Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange added 14 more shares to over-the-counter trading

8/16/24 MOEX

Moscow Exchange may become a broker

8/16/24 MOEX

Sovcomflot reports for 6 months of 2024 by IFRS

8/16/24 FLOT

Trades in shares of ICAO Headhunter will begin on September 25

8/15/24 HEAD

Cherkizovo reports for 6 6 months of 2024 by IFRS

8/15/24 GCHE

Rosgosstrakh doubles half-year net profit

8/15/24 RGSS

Seligdar plans to start geological exploration of Dzhekondinskaya area in 2025

8/15/24 SELG

Renaissance Insurance will receive VSK - Life Line portfolio

8/15/24 RENI

SFI redeemed 55% of its shares

8/15/24 SFIN

Sovcombank postpones additional share issue for the acquisition of Home Bank to 2025

8/15/24 SVCB